[28] analyzed the risk of cancers associated with GLP-1RAs in patients with T2DM
With the desire to eat and drink less, your fluid intake can be compromised
This toolkit gives you simple, realistic strategies to enjoy the season, reduce side effects, and protect your progress without feeling deprived
New initiatives and regulatory appointments The company recently launched Labs, a subscription based diagnostic platform that transforms premium laboratory work covering heart health, metabolism, inflammation and hormone levels into an accessible service with physician created action plans
Need to assure equitable access With US consumers comprising nearly 75% of current GLP-1 demand worldwide, the greatest concern is equitable access to the new treatments, said Tedros, speaking with journalists earlier this week
The North Carolina Board of Pharmacy, West Virginia Board of Pharmacy, and Mississippi Board of Pharmacy issued warnings about possible enforcement consequences of the use of semaglutide salts in compounding